Top of this page
Skip navigation, go straight to the content

Clinical Studies Overview

Welcome to our
Clinical Studies section

 

UCB researchers seek to understand, prevent and treat diseases.
Clinical studies involving healthy volunteers and patients play a vital role in the development of new drugs.

 

 



Find out more about a selection of studies

 

Epilepsy in children - "BELLE" study - EP0065

A Multicenter, Open-Label Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Intravenous Brivaracetam in Subjects = 1 Month to < 16 Years of Age with Epilepsy.

Recruiting

Status
Epilepsy in children - "ACHIEVE" study - SP0967

A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Investigate the Efficacy and Safety of Lacosamide as Adjunctive Therapy in Subjects with Epilepsy >=1 Month to <4 Years of Age with Partial-Onset Seizures.

Recruiting

Status

Nonradiographic axial spondyloarthritis - "BE MOBILE 1" study - AS0010

www.bemobilestudy.com

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled StudyA Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Bimekizumab in Subjects With Active Nonradiographic Axial Spondyloarthritis.

Recruiting

Status

Ankylosing spondylitis - "BE MOBILE 2" study - AS0011

www.bemobilestudy.com

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Bimekizumab in Subjects With Active Ankylosing Spondylitis.

Recruiting

Status

Psoratic arthritis - "BE OPTIMAL" study - PA0010

www.beoptimalstudy.com

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Active Reference (Adalimumab) Study Evaluating the Efficacy and Safety of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis.

Recruiting

Status

Psoratic arthritis - "BE COMPLETE" study - PA0011

www.becompletestudy.com

A Multicenter, Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis.

Recruiting

Status

Drug-resistant Epilepsy - "DUET" study - EP0092

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Padsevonil as Adjunctive Treatment of Focal-Onset Seizures in Adult Subjects With Drug-Resistant Epilepsy

Recruiting

Status

Discover more about our clinical studies

Interested in enrolling in our study?

Just contact us

Belgium

UCBCares.BE@ucb.com
+32 2 559 92 00
0800 38 008 (freephone)
www.ucbcares.be

Bulgaria

UCBCares.BG@ucb.com
+359 2 962 9933

Czech Republic

UCBCares.CZ@ucb.com
+420 221 773 442
800 144 395 (freephone)

Denmark

UCBCares.DK@ucb.com
+45 32462480
80 253827 (freephone)

Finland

UCBCares.FI@ucb.com
+358 9 2514 4243
0800 9 13353 (freephone)

France

UCBCares.FR@ucb.com
+33 1 47 29 45 55
8052-22949 (freephone)

Germany

UCBCares.DE@ucb.com
+49 2173 48 48 48
www.ucbcares.de

Greece

UCBCares.GR@ucb.com
+30 21 0997 4200
0080 012 9910 (freephone)

Hungary

UCBCares.HU@ucb.com
+36 1 346 3060
06 80 021 486 (freephone)

Ireland

UCBCares.IE@ucb.com
+353 1 463 2371
1800 93 00 75 (freephone)
www.ucbcares.co.uk

Italy

UCBCares.IT@ucb.com
+39 02 3007 9300
8009-86932 (freephone)
www.ucbcares.it

Luxemburg

UCBCares.LU@ucb.com
+32 2 559 92 12
8002 3204 (freephone)

Norway

UCBCares.NO@ucb.com
+45 32462482
800-10101 (freephone)

Poland

UCBCares.PL@ucb.com
+48 22 596 97 97
00 800 121 68 25 (freephone)

Portugal

UCBCares.PT@ucb.com
+351 213 025 300
00 800 121 68 25 (freephone)

Slovakia

UCBCares.SK@ucb.com
+421 2 592 020 23
0800 002 566 (freephone)

Spain

UCBCares.ES@ucb.com
+34 915 70 06 49
8000-99684 (freephone)
www.ucbcares.es

Sweden

UCBCares.SE@ucb.com
+45 32462481
0200 898 671 (freephone)

The Netherlands

UCBCares.NL@ucb.com
+31 76 573 1130
0800 343435 (freephone)

UK

UCBCares.UK@ucb.com
+44 1753 777 100
0800 279 3177 (freephone)
www.ucbcares.co.uk

Inspired by patients, driven by science
 
 

 

Disease resources

Learn more about epilepsy
Rheumatoid arthritis
Learn more about osteoporosis
Learn more about psoriasis
Parkinson's disease
Restless Legs Syndrome
Psoriatic arthritis
Axial Spondyloarthritis
Learn more about juvenile idiopathic arthritis
Learn more about lupus
Crohn's disease